chrisvoncsefalvay/vaers-outcomes huggingface dataset:
PATIENTS ARM BECOME SWOLLEN, RED AND SEVERLEY IRRITATED.  SHOWED ARM TO ME THE FOLLOWING DAY (10/07/2014) AND LOOK VERY SWOLLEN AND PAINFUL.
Chills, aches, cough, shortness of breath, nausea and vomiting, fatigue, diarrhea, difficulty breathing, no appetite
Pt called the pharmacy on 2/25/19 stating that her arm had a red, warm, blotchy rash. She stated this rash was not directly at the injection site but surrounding. She stated that the rash traveled up to her shoulder and underneath her arm pit. She stated she was not feeling well but was unsure if she had a fever.
Patient's wife  called and reported that patient  has a lump under the armpit.  Advised pt to see md if it doesn't get better
Achy after second vaccination; Headache after second vaccination; Chill after second vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achy after second vaccination), HEADACHE (Headache after second vaccination) and CHILLS (Chill after second vaccination) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN (Achy after second vaccination), HEADACHE (Headache after second vaccination) and CHILLS (Chill after second vaccination). At the time of the report, PAIN (Achy after second vaccination), HEADACHE (Headache after second vaccination) and CHILLS (Chill after second vaccination) outcome was unknown.            No concomitant medications were reported.  Treatment information was not provided.
Post vax, the pt developed swelling at the injection site which extended to the fingers. The pt was seen in the ER. No further information available.
PT. RECEIVED A FLU SHOT 12-12-06 AT 3:45PM AT OUR PUBLIC HEALTH CLINIC (HER HUSBAND ALSO RECEIVED A FLU SHOT AT THE SAME TIME, WITH THE SAME SERUM, AND RECEIVED NO REACTION) WITH IN A FEW HOURS SHE EXPERIENCED A HEADACHE, OVERALL BODY ACHES, FEVER, (DID NOT TAKE HER TEMPERATURE) WAVES OF NAUSEA AND VIOLENT SHAKING FOR AN HOUR AND 45 MINUTES. IT WAS SEVERE ENOUGH THAT SHE HAD HER HUSBAND CALL HER DOCTOR. SHE REPORTED SPINAL STENOSIS ON HER CONCENT FORM FOR A CHRONIC MEDICAL CONDITION, AND HAS HAD MANY PRIOR FLU SHOTS WITHOUT INCIDENT. SHE CALLED THIS MORNING TO SEE IF ANY OTHER PERSON HAD SIMILIAR EXPERIENCES AND REPORTED THAT SHE STILL FELT WEAK AND WASHED OUT BUT BETTER.
Trouble getting up; Fatigue; Chills; arm was swollen at injection site "little bigger than first one"; arm felt very painful; Fever for 3 days; in cold sweats; got hot really quickly; Taste Buds are off; Feeling dizzy; Smell was off; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (in cold sweats), FEELING HOT (got hot really quickly), AGEUSIA (Taste Buds are off), DIZZINESS (Feeling dizzy) and ANOSMIA (Smell was off) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006C21A and 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced COLD SWEAT (in cold sweats), FEELING HOT (got hot really quickly), AGEUSIA (Taste Buds are off), DIZZINESS (Feeling dizzy), ANOSMIA (Smell was off), VACCINATION SITE SWELLING (arm was swollen at injection site "little bigger than first one"), VACCINATION SITE PAIN (arm felt very painful) and PYREXIA (Fever for 3 days). On an unknown date, the patient experienced SOMNOLENCE (Trouble getting up), FATIGUE (Fatigue) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COLD SWEAT (in cold sweats), FEELING HOT (got hot really quickly), AGEUSIA (Taste Buds are off), DIZZINESS (Feeling dizzy), SOMNOLENCE (Trouble getting up), VACCINATION SITE SWELLING (arm was swollen at injection site "little bigger than first one"), VACCINATION SITE PAIN (arm felt very painful), PYREXIA (Fever for 3 days), FATIGUE (Fatigue) and CHILLS (Chills) outcome was unknown and ANOSMIA (Smell was off) was resolving.            No concomitant medications were reported.   This case was linked to MOD-2021-262876 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 10-Sep-2021: Follow-up received includes Updated outcome of event Anosmia from unknown to recovering/resolving. pregnancy information updated to unknown.
Sudden onset of extreme vaginal pain, blood in urine. Tests/exams were done but nothing unusual was found. There was no treatment. Problem resolved after about 12 days.
12:00p Pt experiencing some burning to vaccination arm, mild redness, no other symptom. VS 135/79, R 20, P76, 02 95%. Zyrtec 10mg adm po. Pt left in no acute distress at 12:15p. Advised to seek medical attention should symptoms recur.
Presented with SOB, cough, N/V, loss of smell/tast x3 days; Covic dx 5 days PTA; hypoxic in ED, Spo2 high 80's; 2 LPM O2 in ED; 9/14 admit to obs medical; 9/17 changed to inpatient medical; tx: 9/14 steroids, lovenox,  zinc 9/15 Vit C, Zithromax, rocephin, 9/16 vit B12   9/17 remdesivir (x5 days), 9/18 baricitinib, singulair, O2 requirements; Initially on 2 LPM; 9/17 7 LPM, 9/18 Airvo up to Arivo 50L/70% on 9/19 then slowly back down to 2 LPM at time of d/c on 9/23
Red, non-raised rash at the injection site a little larger than a quarter and slightly itchy.
no adverse event; 21 year old patient got his 1st dose of MMR II a month ago.; This spontaneous report as received from a pharmacist refers to a 21-year-old male patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.    On an unknown date in November 2020 (reported as a month ago), the patient was vaccinated with the first dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis, therefore experienced product administered to patient of inappropriate age. No additional adverse event was reported. The outcome of product administered to patient of inappropriate age and no adverse event was unknown.
Within in 12 hours of the vaccine I had dizziness, nausea and body aches/chills. Three Days after vaccine I had severe chest pain, in the center of my chest. I woke me up all night because it was so painful. Immediately went to ER at 7am the next morning, the 4th day. Had several tests done at ER and they couldn't find anything wrong. They told me if it persists to go to PCP. This pain continued for 3 weeks, just in time for 2nd dose. My Oncologist recommended I wait a couple months before getting the 2nd dose due to the chest pain.
This case was reported by a healthcare professional and described the occurrence of decreased therapeutic response in a 45-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). On 31 March 2009, the subject received 1st dose of ENGERIX B (1 ml, unknown, unknown). On 19 May 2009, the subject received 2nd dose of ENGERIX B (1 ml, unknown, unknown). On 27 August 2009 the subject received 3rd dose of ENGERIX B (1 ml, unknown, unknown) and experienced decreased therapeutic response and drug dose administration interval too short. On an unspecified date, the subject's titer was less than 0.1 with a decreased therapeutic response. The nurse reported that the first and second dose were from the same lot number. The third dose was from another lot number. The nurse reported that the titers were showing that the series of ENGERIX-B that she provided to the workers at her assisted living facility did not work. Specifically the report stated that the subject was not immune and needed to restart series. The subject's titer was less than 0.1. It was determined that the third dose in the series was administered five months from the first vaccine instead of the recommended six months. This is one of nine cases reported by the nurse; see cases A0832030A, A0832033A, and A0832034A for female subjects who experienced decreased therapeutic response and drug dose interval too short; and see cases A0832032A, A0832102A, A0832103A, and A0832104A for female subjects who experienced drug dose interval too short.
Symptoms began within 15 minutes of vaccination.  C/o shortness of breath/chest tightness, "wheezing," had 1 episode of diarrhea.  Sent to ED, given tylenol, zofran ODT, solumedrol, diphenhydramine injection. Diagnosed with allergic reaction and discharged to home with oral steroid.
Started 3/27/02 with fever, fussiness, rash. Went to doctor. Also had ear infection. Got antibiotic. By 4/1/02, fever gone, rash almost gone. On Lorabid. Highest fever 103 axillary.
soreness at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness at site of injection) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included HYDROXYCHLOROQUINE and MELOXICAM for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PAIN (soreness at site of injection). At the time of the report, VACCINATION SITE PAIN (soreness at site of injection) outcome was unknown.            No concomitant medications were reported.  No treatment medications were reported.  Patient took second dose on 12-APR-2021.  Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-075612 (Patient Link).
Six hours after receiving Covid vaccine, employee broke out in hives starting from ankles to neck, took Benadryl at home and tried Hydrocortisone Cream with no relief. 12/29 seen in the Urgent Care recommended Treatment of Zytec 3-4 tablets  and 2 Zantac that day.  12/30 hives resolving.
Patient received 3 vaccines around 1045AM. I returned to the exam room about 4 minutes later with a copy of vaccine record - patient was dressed and had his winter coat on - no issues noted. Around 11AM - patient and mother are at registration area - checking out - patient is crying, and scratching his body - clerk called triage nurse. Patient was given BENADRYL. Face swollen and body red, hot with hives EPIPEN Jr. administered approximately 1110 AM. Ambulance called to Health Center. Patient and mother transported to ECU.
skin sensitivity; 103-104F fever for 12 hours (beginning 12 hours post injection); vomiting; This is a spontaneous report from a contactable consumer (patient) or other non hcp.  A 39-years-old (non-pregnant) female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EW0167, Expiration date: unknown), via an unspecified route of administration on 04May2021, 10:00 AM (at the age of 39-years-old) as dose 1, single for covid-19 immunisation. Medical history included hypothyroidism, Chronic active Epstein-Barr virus infection (caEBV). Concomitant medication included levothyroxine sodium, bupropion hydrochloride (WELLBUTRIN), aciclovir sodium (ACYCLOVIR ABBOTT VIAL), calcium pantothenate, folic acid, vitamins nos (MULTI-VITAMINS VITAFIT) all taken for unspecified indication start and stop date were not reported. Prior to vaccination,  patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On 04May2021, at 22:00 the patient experienced skin sensitivity, 103-104f fever for 12 hours (beginning 12 hours post injection), vomiting. Prior to vaccination patient was not diagnosed with COVID-19. Since the vaccination, patient had been not tested for COVID-19. The patient underwent lab tests and procedures which included body temperature 103-104 Fahrenheit on 04May2021. The outcome of events was recovering.  No follow-up attempts are needed. No further information is expected.
Fever to 101.5 for 2 days, shortness of breath when I walk short distance, shaking chills, sweating, severe joint pains, fatigue, malaise, loss of appetite, need to sleep constantly. Treated with Tylenol, Aleve and sleep. Felt too sick to go out to the doctor's office.
This spontaneous report as received from a healthcare worker refers to an unspecified number of unknown age and unknown gender. On an unknown date, the unspecified number of patients were vaccinated with improperly stored RECOMBIVAX HB (lot # K010238 and expiry date: 14-APR-2016) that was no supported. No adverse effects were reported. No product quality complaint (PQC) was reported for RECOMBIVAX HB. This is one of the several reports from the same reporter. Additional information has been requested.
pt recv vax & 18DEC96 pt had many papular lesions w/small vesicles;pt was treated w/DPH & recovered by JAN97;
Fever, achy body, felt like I was coming down with the flu. Lasted about 3 hours. This happened the same time the next day too. Fever over 100 degrees both days.
Nausea, vomiting, fever greater than 102, light headed, weak, diarrhea, hives. Just resting at home and taking Tylenol cold and flu and drinking plenty of fluids.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 07-DEC-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001529, expiration date 07-NOV-2020) and ROTATEQ (lot # R015432, expiration date 15-APR-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccines were exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
HEAVINESS IN LEG; CHILLS; FEVER; NAUSEA; FATIGUE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 09-APR-2021 16:30 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced heaviness in leg. On APR-2021, the subject experienced chills. On APR-2021, the subject experienced fever. On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced fatigue. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, nausea, fatigue and heaviness in leg was not reported. This report was non-serious.
After injection at 2:33 pm on the date above, Rainbow began to experience, dizziness, fever, sore throat, severe arm pain.  Today, the next morning, she is weak, tired, and still has sore throat.
Sore arm when woke up at 6am ,backache at 9:15am for arm used therawork relief foam when started hasn't worked yet, haven't done anything for the back and headache at 9:30 am haven't done anything for headache
This spontaneous report was received from a registered nurse refers to a patient of unknown age. On 19-SEP-2013, the patient was vaccinated with first dose of GARDASIL (lot number, expiry date and route was not reported). On 23-OCT-2013, the patient was vaccinated with second dose of GARDASIL (lot number, expiry date and route was not reported). No adverse symptoms were reported. Additional information has been requested.
After painful hospital overnight visit was found also to have shingles.  Following week went back to emergency room in same hospital for severe shingles pain
Patient reported to pharmacy that she woke up experiencing high fever (103 degrees) as well as soreness in the injection arm. Patient is self treating with antipyretics and analgesics and will seek treatment from a physician if incomplete resolution within a reasonable time.
Case number PHHY2011US36774 is an initial spontaneous report received from a health care professional on 26 Apr 2011. This report refers to a 12 years old male patient. He was vaccinated with MENVEO (batch number: unknown) intramuscularly on 25 Apr 2011. Three to four hours after vaccination, he experienced severe headache, dizziness, blurriness and emesis. He was taken to emergency room with complaints of a migraine headache and continuous vomiting. He experienced headache until 24 hours after vaccination. The health care professional assessed the events as serious (medically significant and hospitalization) and the outcome of the events was reported as complete recovery. This case was also reported to the VAERS.
Chills, 102 degree fever for 48 hours, nausea/vomiting beginning 6 hours after injection and continuing all night (duration 6-8 hours), inability to keep any liquids down for 12+ hours, queasy for 24 hours after vomiting stopped, diarrhea 24 hours after injection, continued intestinal discomfort 48+ hours after injection. Sore arm at injection site still on-going.
This pt received first two doses of hepatitis B vax in 1988. On 02/18/00, she received the third. Within the same month, she experienced an increase in her liver function tests and was then dxed with Epstein-Barr virus. Follow-up information indicated that approximately 20 days post vax, on 03/10, she developed nausea, vomiting, elevated liver enzymes, lymphadenopathy in her neck, and urticaria on her body. The pt was initially seen in the physician's office and later in the week, 03/10, she presented to the ER and was admitted to the hospital. Labs were conducted. The physician noted on her admission that there was a possibility that she had a sub-clinical hepatic reaction to the vax. At the time of hospitalization, the etiology was unclear. Gallbladder ultrasound, CT abdomen scan were all within nml limits. The biliary tree was not dilated. The gallbladder appears to be very small, however, contracted and contained small ill defined opacities which may represent biliary sludge of tiny gallbladder calculi. The spleen was mildly enlarged and show homogeneous attenuation. The pancreas, adrenal glands and kidneys are within nml limits. There is no evidence of free fluid in the pelvic cavity. The impression was top normal size liver, mild splenomegaly, small contracted gallbladder, probably secondary to cholecystitis. There are small faint opacities with the lumen of the gallbladder calculi. The remainder of the CT scan was unremarkable. According to the physician, this pt was febrile to 103.1 F in the past, but currently afebrile. Other vitals were unremarkable. Ear, nose and throat assessment showed slight icterus. Significant lymphadenopathy in the anterior cervical chains were noted in the neck exam. Heart, lungs, abdomen, and neurologic exam nml. Extremities had no edema but showed urticaria on face, neck, trunk and arms. The impression was elevated liver enzymes with lymphadenopathy and urticaria, the differential of this condition is long, however the physician believed the possibility of two concurrent conditions was likely. He reported mononucleosis with concurrent chemical dermatitis; subclinical hepatitis from clinical agent causing contact dermatitis or subclinical hepatitis from Hepatitis B vax, possible common bile duct obstruction, concurrent dermatitis. The plan was hydration and observation. The pt was discharged on 03/11. She was observed and 3rd set of liver enzymes was significantly improved but bilirubin was essentially unchanged. She feels well, is eating, somewhat nauseated, but not vomiting. She was discharged to bed rest and was restart Medrol Dosepak and follow up with physician on 03/13.
My jaw and my neck are all tender and they look swollen, it goes down my shoulder and down my arm; My jaw and my neck are all tender and they look swollen, it goes down my shoulder and down my arm; My jaw and my neck are all tender and they look swollen, it goes down my shoulder and down my arm; My jaw and my neck are all tender and they look swollen, it goes down my shoulder and down my arm; My arms real sore from this shot; My jaw started to hurt; This is a spontaneous report from a contactable consumer or other non hcp (Patient).   A patient of unspecified age and gender received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) via an unspecified route of administration on 18Mar2021 as dose 1, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Consumer stated, I got my vaccine yesterday, my first one and on 18Mar2021, patient experienced my jaw started to hurt last night, on 19Mar2021, patient experienced my jaw and my neck are all tender and they look swollen, it goes down my shoulder and down my arm, my arms real sore from this shot. At the time of reporting, the outcome of the events were unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Acute on chronic diastolic congestive heart failure; Epistaxis; Hypoxia; Shortness of breath
The first vaccine took away some of his long-haulers symptoms/It took away his tremors and it took away his fogginess of the brain.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 76 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 (Lot number: ER8727, Expiration Date: 31Jul2021) at the age of 76 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing), notes: had for a couple years, 2 and a half years maybe; "Covid-19" (unspecified if ongoing), notes: He had Covid once in August and once again in December. Concomitant medication(s) included: OLMESARTAN taken for blood pressure increased; BESILATE D'ATRACURIUM taken for blood pressure increased. The following information was reported: THERAPEUTIC RESPONSE UNEXPECTED (non-serious), outcome "unknown", described as "The first vaccine took away some of his long-haulers symptoms/It took away his tremors and it took away his fogginess of the brain.". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: patient has been on concomitant medications for a year or year and a half. Investigation Assessment: No. History of all previous immunization with the Pfizer vaccine considered as suspect: none. All vaccines administered on same date with the Pfizer vaccine considered as suspect: none. Other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s): none. Family Medical History Relevant to AEs: none  No follow-up attempts are possible. No further information is expected.
It felt like my wrist was burning and stinging with pain. My entire arm starting to swell with the pain creeping up my arms and wrist. It went into the glands under my left arm causing swelling pain when it pressed on. I was told by my doctor that I got COVID-19 arm after a week after the shot. It took about six weeks or so before it started to go down.